Last week the US FDA refused to approve the Moderna mRNA flu vaccine because of the inadequacy of trial design.
Right away the virulence and reach of...
A paper published in the Journal of the American Geriatric Society entitled "Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed-methods study" throws a...
On the Friday before Christmas, Health New Zealand quietly released the 2023 New Zealand cancer data to a media preoccupied with end of year holiday trivia. Not...
The NY Times is heralding a new company called Mechanize formed in San Francisco to produce software with the 'audacious' (???) goal of replacing 50% of white collar...
If you read the newspapers you may not know it, but biotechnology is going through a process of collapse.
According to authoritative pharmaceutical industry...
